SiriusPoint 경영진
경영진 기준 점검 3/4
현재 CEO에 대한 정보가 충분하지 않습니다.
핵심 정보
Scott Egan
최고경영자
US$9.8m
총 보수
| CEO 급여 비율 | 11.91% |
| CEO 재임 기간 | 4yrs |
| CEO 지분 보유율 | 1.2% |
| 경영진 평균 재임 기간 | 3.5yrs |
| 이사회 평균 재임 기간 | 4yrs |
최근 경영진 업데이트
Recent updates
Seeking Alpha • Sep 11
Tracking Dan Loeb's Third Point Portfolio - Q2 2026 Update
Summary Third Point's Q2 2026 13F portfolio doubled to $4.68B, with the top three holdings comprising ~30% of assets. Warner Brothers Discovery became the largest position at 11.39%, established this quarter at $26–$28, and is now trading at $28.20. Significant new stakes include Keysight Technologies, Block Inc., Flex Ltd., and Norfolk Southern, while Meta Platforms and Nvidia were fully exited. Major increases were made in Alphabet, CRH plc, Taiwan Semi, and Live Nation, reflecting a dynamic, concentrated portfolio strategy. Read the full article on Seeking Alpha
내러티브 업데이트 • Jul 13
SPNT: Buy Rating And Crisis Expansion Will Guide Earnings And Margins
Analysts have adjusted their price target on SiriusPoint to $25.00 from $23.00, citing updated assumptions around revenue growth, profit margins, and future P/E multiples informed in part by recent Street research coverage. What’s in the News for SiriusPoint SiriusPoint was removed from the Russell 2500 Growth Benchmark index, according to recent index constituent changes.
내러티브 업데이트 • Jun 29
SPNT: Resumed Buy Rating And Capital Returns Will Drive Bullish Repricing
Analysts have raised their SiriusPoint price target from $24 to $27, citing updated assumptions around discount rates, profit margins, and future P/E that they view as better aligned with the stock's current risk and earnings profile. What’s in the News for SiriusPoint SiriusPoint was removed from several Russell growth and small cap benchmarks, including the Russell 3000 Growth, Russell 2500 Growth, Russell 2000 Growth, Russell 3000E Growth, Russell Small Cap Comp Growth, and Russell 2000 Growth-Defensive Indexes.내러티브 업데이트 • Jun 15
SPNT: Buy Rating And Crisis Lines Expansion Will Shape Earnings And Margins
Analysts have adjusted their price target on SiriusPoint to $23.00, citing updated assumptions for revenue growth, profit margins, and future P/E that align with recent research coverage resuming on the stock. What's in the News SiriusPoint launched a new Crisis Solutions class of business within its London Market Specialty division, focused on building underwriting, exposure management, and claims capabilities in this area.내러티브 업데이트 • Jun 01
SPNT: Reorganization And Buy Rating Will Shape Earnings And Margin Delivery
Narrative Update on SiriusPoint Analysts have kept their SiriusPoint price target steady at $23.00, with the unchanged fair value supported by expectations for revenue growth alongside slightly firmer profit margins and a modestly lower assumed future P/E multiple. Analyst Commentary Recent Street commentary on SiriusPoint has focused on how current expectations and the US$23.00 target line up with execution and valuation risks.내러티브 업데이트 • May 04
SPNT: Reorganization And Buy Rating Will Test Execution And Earnings Resilience
Analysts have modestly raised their $23.00 price target on SiriusPoint, reflecting updated assumptions around revenue, profit margins, and future P/E. This revision is supported by renewed Buy-rated coverage from the Street.내러티브 업데이트 • Apr 20
SPNT: Neutral Outlook Will Weigh Reorganization Benefits Against Execution And Earnings Risks
Analysts have adjusted their SiriusPoint price target to $23.00, with the change supported by updated assumptions around slightly higher revenue growth, an improved profit margin outlook, and a lower future P/E multiple. Analyst Commentary Recent Street research around SiriusPoint centers on whether the current share price already reflects the updated $23.00 target, especially given the revised assumptions on revenue, margins, and a lower future P/E multiple.내러티브 업데이트 • Apr 03
SPNT: Neutral Outlook Will Balance Capital Moves With Execution And Earnings Risks
The analyst price target for SiriusPoint has increased from $22 to $23, with analysts citing revised assumptions around fair value, revenue growth, profit margin, and future P/E to support this change. Analyst Commentary Recent research coverage has taken a measured stance on SiriusPoint, with the new analysis tending to frame the current price target in the context of execution risk, valuation assumptions, and the durability of earnings.내러티브 업데이트 • Mar 20
SPNT: Neutral Coverage And Capital Moves Will Set Up Bullish Repricing
Analysts trimmed their price target on SiriusPoint by $0.59 due to slightly lower profit margin assumptions and a higher future P/E multiple following recent neutral research coverage. Analyst Commentary Recent neutral research coverage frames SiriusPoint as fairly balanced at current levels, with the trimmed price target reflecting fine tuning of profit margin expectations and a higher assumed future P/E multiple rather than a major shift in the core thesis.내러티브 업데이트 • Mar 06
SPNT: Neutral Rating And Share Actions Will Set Up Rerating Potential
Narrative Update on SiriusPoint Analysts have reset their price target on SiriusPoint from $27.50 to $24.00, citing revised assumptions around growth, profitability, discount rates and a higher future P/E multiple, alongside recent neutral research coverage. Analyst Commentary Recent research coverage on SiriusPoint has taken a neutral stance overall, focusing on how updated assumptions around growth, profitability and discount rates line up with the new US$24.00 price target.내러티브 업데이트 • Feb 19
SPNT: Neutral Stance Will Weigh Capital Simplification Against Execution Risks
Analysts have maintained their $22.00 price target on SiriusPoint, citing updated assumptions for revenue growth, profit margins, and future P/E, along with the recent neutral initiation of coverage by Raymond James. Analyst Commentary Recent research commentary around SiriusPoint has leaned cautious, with the neutral initiation signaling that some analysts see a balance between potential upside and key execution risks.내러티브 업데이트 • Feb 05
SPNT: Neutral Outlook Will Weigh Capital Simplification Against Execution Risks
Analysts have lifted their price target on SiriusPoint from US$21.00 to US$22.00, citing updated assumptions around revenue growth, profit margins, and future P/E as key drivers of the change. Analyst Commentary Recent Street research on SiriusPoint, including a neutral initiation, points to a more balanced view, where potential upside is weighed against clear execution and valuation risks.내러티브 업데이트 • Oct 04
Rising Global Reinsurance Demand Will Unlock Specialty Potential
Analysts have raised their price target for SiriusPoint from $25.33 to $27.50. This reflects a more optimistic outlook based on slightly higher projected revenue growth and modest adjustments in key valuation metrics.분석 기사 • Jul 24
Potential Upside For SiriusPoint Ltd. (NYSE:SPNT) Not Without Risk
With a price-to-earnings (or "P/E") ratio of 15.4x SiriusPoint Ltd. ( NYSE:SPNT ) may be sending bullish signals at the...새로운 내러티브 • Jun 29
Refined Underwriting And Climate Reinsurance Will Unlock Opportunities
Enhanced specialty underwriting and analytics are driving sustainable earnings growth, increased profitability, and improved operating efficiency.분석 기사 • May 14
We Think Shareholders Are Less Likely To Approve A Large Pay Rise For SiriusPoint Ltd.'s (NYSE:SPNT) CEO For Now
Key Insights SiriusPoint will host its Annual General Meeting on 20th of May CEO Scott Egan's total compensation...분석 기사 • Mar 13
It's A Story Of Risk Vs Reward With SiriusPoint Ltd. (NYSE:SPNT)
With a price-to-earnings (or "P/E") ratio of 13.3x SiriusPoint Ltd. ( NYSE:SPNT ) may be sending bullish signals at the...분석 기사 • Aug 26
Not Many Are Piling Into SiriusPoint Ltd. (NYSE:SPNT) Just Yet
There wouldn't be many who think SiriusPoint Ltd.'s ( NYSE:SPNT ) price-to-sales (or "P/S") ratio of 0.9x is worth a...분석 기사 • May 08
Investors Holding Back On SiriusPoint Ltd. (NYSE:SPNT)
There wouldn't be many who think SiriusPoint Ltd.'s ( NYSE:SPNT ) price-to-sales (or "P/S") ratio of 0.8x is worth a...Seeking Alpha • Mar 06
Tracking Dan Loeb's Third Point Portfolio - Q4 2023 Update
Summary Dan Loeb's 13F portfolio value increased to $6.64B this quarter, with the top three holdings accounting for ~37% of the portfolio. Third Point returned 3.4% in 2023 compared to 26.3% for the S&P 500 Index. New stakes include Fleetcor Tech, Verizon, Apollo Global Management, McKesson Corp, EQT Corp, and Biomarin Pharma. Read the full article on Seeking Alpha분석 기사 • Jan 23
SiriusPoint Ltd. (NYSE:SPNT) Could Be Riskier Than It Looks
With a median price-to-sales (or "P/S") ratio of close to 1x in the Insurance industry in the United States, you could...Seeking Alpha • Jan 22
Revisiting SiriusPoint Common And Preferred
Summary SiriusPoint's preferred units have shot up nicely in recent months, generating strong returns for shareholders. SPNT's financial health has improved, with increased profits and a decline in some activities. The common units are still rated a 'buy' due to increased profitability, but the limited upside that remains necessitates a downgrade for the preferred units. Read the full article on Seeking AlphaSeeking Alpha • Sep 25
SiriusPoint Offers Extremely Undervalued 9.3% Bond And An Excellent Preferred Stock
Summary We first revisit our recommendation of SiriusPoint preferred stock from May of this year. Although SPNT-B has been a big winner for us since May, it is still the most undervalued among “qualified” BB+ rated preferred stocks plus it has a massive reset rate. At the current 5-year treasury note yield, the reset yield on SPNT-B will be 12% and it trades below par. SiriusPoint also offers an extremely undervalued bond with an investment grade BBB rating and an approximate 9.3% yield-to-maturity (YTM). A typical BBB bond has a YTM of around 6.3% making this 9.3% YTM bond the most undervalued bond in the market based on credit rating (in my opinion). Read the full article on Seeking AlphaCEO 보수 분석
| 날짜 | 총 보수 | 급여 | 회사 수익 |
|---|---|---|---|
| Jun 30 2026 | n/a | n/a | US$495m |
| Mar 31 2026 | n/a | n/a | US$485m |
| Dec 31 2025 | US$10m | US$1m | US$443m |
| Sep 30 2025 | n/a | n/a | US$186m |
| Jun 30 2025 | n/a | n/a | US$103m |
| Mar 31 2025 | n/a | n/a | US$149m |
| Dec 31 2024 | US$9m | US$1m | US$176m |
| Sep 30 2024 | n/a | n/a | US$281m |
| Jun 30 2024 | n/a | n/a | US$330m |
| Mar 31 2024 | n/a | n/a | US$277m |
| Dec 31 2023 | US$10m | US$1m | US$315m |
| Sep 30 2023 | n/a | n/a | US$201m |
| Jun 30 2023 | n/a | n/a | US$49m |
| Mar 31 2023 | n/a | n/a | -US$64m |
| Dec 31 2022 | US$7m | US$320k | -US$403m |
보상 대 시장: Scott의 총 보수(USD9.82M)는 US 시장에서 비슷한 규모 기업의 평균(USD6.99M)보다 높습니다.
보상과 수익: Scott의 보상은 지난 1년 동안 회사 실적과 일치했습니다.
CEO
Scott Egan (55 yo)
4yrs
재임 기간
US$9,824,137
보수
Mr. Scott Egan, ACMA, MBA, is Chairman of SiriusPoint International Försäkringsaktiebolag (publ). Mr. Egan serves as Chief Executive Officer of SiriusPoint Ltd. since September 21, 2022 and serves as its D...
리더십 팀
| 이름 | 직위 | 재임 기간 | 보수 | 지분 |
|---|---|---|---|---|
| CEO & Director | 4yrs | US$9.82m | 1.15% $ 32.3m | |
| Group President & Chief Executive Officer of Global Reinsurance and London Market Speciality | 3.8yrs | US$3.57m | 0.54% $ 15.1m | |
| CFO & Principal Accounting Officer | 2.3yrs | US$2.93m | 0.012% $ 345.8k | |
| Global Head of Accident & Health (A&H) | 4.7yrs | US$2.64m | 0.19% $ 5.5m | |
| Chief Operating Officer | less than a year | 데이터 없음 | 데이터 없음 | |
| Chief Investment Officer | less than a year | 데이터 없음 | 데이터 없음 | |
| Chief Information & Technology Officer | 4.4yrs | 데이터 없음 | 데이터 없음 | |
| Investor Relations & Strategy Manager | no data | 데이터 없음 | 데이터 없음 | |
| Chief Legal Officer & Corporate Secretary | 3.2yrs | 데이터 없음 | 데이터 없음 | |
| Chief Strategy & Corporate Development Officer | 1.3yrs | 데이터 없음 | 데이터 없음 | |
| Interim Chief Human Resources Officer | no data | 데이터 없음 | 데이터 없음 | |
| Global Head of Specialty | 12.8yrs | US$1.66m | 데이터 없음 |
3.5yrs
평균 재임 기간
55yo
평균 나이
경험이 풍부한 관리: SPNT의 경영진은 경험이 있음으로 간주됩니다(평균 재임 3.5 년).
이사회 구성원
| 이름 | 직위 | 재임 기간 | 보수 | 지분 |
|---|---|---|---|---|
| CEO & Director | 4yrs | US$9.82m | 1.15% $ 32.3m | |
| Independent Chairman | 3.3yrs | US$237.50k | 0.057% $ 1.6m | |
| Director | 4.3yrs | 데이터 없음 | 3.24% $ 91.1m | |
| Independent Director | 2.3yrs | US$150.61k | 0.021% $ 578.0k | |
| Independent Director | 6.1yrs | US$158.33k | 0.11% $ 3.0m | |
| Independent Director | less than a year | 데이터 없음 | 0.0051% $ 142.8k | |
| Independent Director | 4.5yrs | US$158.33k | 0.084% $ 2.4m | |
| Independent Director | 5.6yrs | US$189.45k | 0.14% $ 3.9m | |
| Independent Director | 1yr | US$192.98k | 0.0083% $ 232.2k |
4.0yrs
평균 재임 기간
63yo
평균 나이
경험이 풍부한 이사회: SPNT의 이사회는 경험이 있음으로 간주됩니다(평균 재임 4 년).
기업 분석 및 재무 데이터 상태
| 데이터 | 최종 업데이트 (UTC 시간) |
|---|---|
| 기업 분석 | 2026/09/13 23:16 |
| 종가 | 2026/09/11 00:00 |
| 수익 | 2026/06/30 |
| 연간 수익 | 2025/12/31 |
데이터 소스
당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.
| 패키지 | 데이터 | 기간 | 미국 소스 예시 * |
|---|---|---|---|
| 기업 재무제표 | 10년 |
| |
| 분석가 컨센서스 추정치 | +3년 |
|
|
| 시장 가격 | 30년 |
| |
| 지분 구조 | 10년 |
| |
| 경영진 | 10년 |
| |
| 주요 개발 | 10년 |
|
* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.
별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.
분석 모델 및 스노우플레이크
이 보고서를 생성하는 데 사용된 분석 모델의 세부 정보는 당사의 GitHub 페이지에서 확인하실 수 있습니다. 또한 보고서 사용 방법에 대한 가이드와 YouTube 튜토리얼도 제공하고 있습니다.
Simply Wall St 분석 모델을 설계하고 구축한 에 대해 알아보세요.
산업 및 섹터 지표
산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.
분석가 소스
SiriusPoint Ltd.는 7명의 분석가가 다루고 있습니다. 이 중 4명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
| 분석가 | 기관 |
|---|---|
| Jay Cohen | BofA Global Research |
| Randy Binner | B. Riley Securities, Inc. |
| Timothy D'Agostino | B. Riley Securities, Inc. |